Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
25.08
-1.01 (-3.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intellia Thera CS
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
August 22, 2023
Via
Benzinga
Topics
Earnings
Exposures
Financial
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
The biotech's focus on innovation could be a boon for shareholders.
Via
The Motley Fool
Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions
August 16, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
August 15, 2023
Via
Benzinga
Barclays Maintains Overweight Rating for Intellia Therapeutics: Here's What You Need To Know
August 07, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Preview: Intellia Therapeutics's Earnings
August 02, 2023
Via
Benzinga
1 Cathie Wood Stock That Could Double Your Money
July 06, 2023
This gene-editing pioneer stands out as a top growth stock to buy right now.
Via
The Motley Fool
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
August 14, 2023
Via
Benzinga
Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter
August 03, 2023
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 24, 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 20, 2023
These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector.
Via
InvestorPlace
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
What 10 Analyst Ratings Have To Say About Intellia Therapeutics
June 13, 2023
Via
Benzinga
Where Intellia Therapeutics Stands With Analysts
June 13, 2023
Via
Benzinga
What Will Amgen Buy Next?
June 29, 2023
The biotech could pursue these two budget-friendly targets.
Via
The Motley Fool
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
June 29, 2023
Reaching profitability could be harder than investors expect.
Via
The Motley Fool
What Is CRISPR And Why Should Your Portfolio Care?
June 25, 2023
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.
Via
Talk Markets
3 Monster Stocks in the Making to Buy Right Now
June 25, 2023
They're not monsters now -- but just give them some time.
Via
The Motley Fool
Wall Street Expects Intellia Therapeutics Stock to Climb 107%. Is That Too Optimistic?
June 23, 2023
Pre-revenue biotechs don't have many ways to juice their share prices.
Via
The Motley Fool
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit?
June 21, 2023
There's more than one reason to sell a stock while buying another.
Via
The Motley Fool
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money.
June 20, 2023
One of these stocks has already doubled this year.
Via
The Motley Fool
Intellia Therapeutics Stock Could Roar in the Next Bull Market. Here's Why.
June 19, 2023
It has quite a few of the core ingredients for success in biopharma.
Via
The Motley Fool
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
June 18, 2023
Success could be in the DNA of the Ark Invest founder.
Via
The Motley Fool
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
3 Cathie Wood Investments That Could Deliver Superior Returns
June 17, 2023
These three stocks fit Wood's profile for big-time growth.
Via
The Motley Fool
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately.
Via
The Motley Fool
2 Growth Stocks Cathie Wood Is Buying Hand Over Fist
June 15, 2023
The fund manager most famous for innovation-focused investing thinks these two stocks have what it takes to produce big gains.
Via
The Motley Fool
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
June 12, 2023
Sunday, Intellia Therapeutics Inc (NASDAQ: NTLA) announced updated interim results from the Phase 1 portion of the ongoing
Via
Benzinga
Why Are Cruise Stocks CCL, RCL, NCLH Up Today?
June 12, 2023
Cruise stocks are on the rise Monday as investors react to a positive note to clients from JPMorgan analysts and we've got the details!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.